decisionhealth Newsletters, Coder Pink Sheets - 2023 Issue 8 (August)
Read up on the rules for reporting JW and JZ modifier on single-use drugs before enforcement Oct 1
Subscribe or sign in to view the full article.
Article Overview
This article reviews recent CMS guidance on the JW and JZ modifiers for single-dose drug containers billed to Medicare Part B. It covers where the modifiers are generally reported, which types of facilities are included or excluded, and the timing of enforcement changes. It is useful for billing, coding, and revenue cycle staff who need a broad understanding of the policy update and the kinds of claims affected.
Why This Topic Matters
The guidance affects how certain drug claims are reported across multiple care settings and highlights a forthcoming enforcement change. Understanding the scope helps practices and facilities determine whether the article is relevant to their billing workflow.
What You Will Learn
- The CMS context for JW and JZ modifier reporting
- Which care settings are discussed in the guidance
- How the article frames the upcoming enforcement timing
- Which broad categories of drug claims and facility types are addressed
- What related CMS FAQ resource the article points to
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle teams
- Physician practice administrators
- Hospital outpatient billing staff
- Pharmacy billing staff
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com